In Silico Evaluation of Cyclophilin Inhibitors as Potential Treatment for SARS-CoV-2

BACKGROUND: The advent of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) provoked researchers to propose multiple antiviral strategies to improve patients’ outcomes. Studies provide evidence that cyclosporine A (CsA) decreases SARS-CoV-2 replication in vitro and decreases mortality rat...

Descripción completa

Detalles Bibliográficos
Autores principales: Laurie, Kyle, Holcomb, David, Kames, Jacob, Komar, Anton A, DiCuccio, Michael, Ibla, Juan C, Kimchi-Sarfaty, Chava
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083350/
https://www.ncbi.nlm.nih.gov/pubmed/34109257
http://dx.doi.org/10.1093/ofid/ofab189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083350/
https://www.ncbi.nlm.nih.gov/pubmed/34109257
http://dx.doi.org/10.1093/ofid/ofab189

Ejemplares similares